Outset, US Renal Care Partner on Home Dialysis

Outset Medical, a medical technology company focused on dialysis solutions, and US Renal Care, the largest privately held kidney care provider in the United States, have partnered to advance home hemodialysis. The two companies have entered a multiyear agreement to offer the Outset Tablo Hemodialysis System as a home dialysis option in the 33 states where US Renal Care operates.

Outset asserted that expanding treatment options in this way will help meet the growing need for in-home dialysis. “Tablo was specifically designed to reduce the complexity of dialysis and help restore the identity and agency of patients who must dialyze to survive. We are pleased to partner with US Renal Care to advance this mission,” said Leslie Trigg, Outset’s chair and chief executive officer.

“We have seen success using the Tablo system in our home hemodialysis program and, with our multiyear agreement with Outset, can continue providing our patients and caregivers access to lifesaving dialysis treatment in an easy-to-operate system, all in the comfort of their own homes,” added Steve Nottingham, US Renal Care co-chief operating officer.

Requiring just tap water and an electrical outlet, Tablo can treat patients with acute and chronic renal failure, with or without ultrafiltration, in acute or chronic care facilities or at home.